Welcome to LookChem.com Sign In|Join Free
  • or
C23H20ClNO4 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

853900-49-9

Post Buying Request

853900-49-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

853900-49-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 853900-49-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,3,9,0 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 853900-49:
(8*8)+(7*5)+(6*3)+(5*9)+(4*0)+(3*0)+(2*4)+(1*9)=179
179 % 10 = 9
So 853900-49-9 is a valid CAS Registry Number.

853900-49-9Downstream Products

853900-49-9Relevant academic research and scientific papers

Psoralen derivatives as inhibitors of NF-κB/DNA interaction: Synthesis, molecular modeling, 3D-QSAR, and biological evaluation

Marzaro, Giovanni,Guiotto, Adriano,Borgatti, Monica,Finotti, Alessia,Gambari, Roberto,Breveglieri, Giulia,Chilin, Adriana

, p. 1830 - 1842 (2013/05/08)

Some new psoralen derivatives were synthesized and evaluated as inhibitors of NF-κB/DNA interaction, with the aim to investigate the structural determinants required to inhibit this interaction. Starting from molecular docking studies, several possible protein binding sites were proposed and several three-dimensional quantitative structure-activity relationship (3D-QSAR) models were built using the docked poses of 29 (the most active psoralen in the series) as templates for alignment of the inhibitors. The selected best model was validated through the prediction of the activity of 17 novel compounds. All the experimental data agreed with the computational experiments, supporting the reliability of the computational approach. The hypothesis about the interaction with NF-κB was also supported by surface plasmon resonance based assays using compound 29. All the collected data allowed the identification of compound 29 as a potential candidate for the development of pharmaceutical strategies against the inflammatory phenotype of cystic fibrosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 853900-49-9